Orphazyme AS (CHIX:ORPHAC) Other Current Receivables : kr14.79 Mil (As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orphazyme AS Other Current Receivables?

Orphazyme AS's Other Current Receivables for the quarter that ended in Jun. 2022 was kr14.79 Mil.

Orphazyme AS's quarterly Other Current Receivables declined from Jun. 2021 (kr43.21 Mil) to Dec. 2021 (kr14.55 Mil) but then increased from Dec. 2021 (kr14.55 Mil) to Jun. 2022 (kr14.79 Mil).

Orphazyme AS's annual Other Current Receivables increased from Dec. 2019 (kr11.28 Mil) to Dec. 2020 (kr18.45 Mil) but then declined from Dec. 2020 (kr18.45 Mil) to Dec. 2021 (kr14.55 Mil).

Orphazyme AS Other Current Receivables Historical Data

The historical data trend for Orphazyme AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Other Current Receivables Chart

Orphazyme AS Annual Data

Trend

Jun14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Current Receivables

Get a 7-Day Free Trial

11.37

14.45

11.28

18.45

14.55

Orphazyme AS Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Other Current Receivables	Get a 7-Day Free Trial									27.74	18.45	43.21	14.55	14.79

Orphazyme AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Orphazyme AS Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (CHIX:ORPHAc) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200

Website

https://www.orphazyme.com

Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS Headlines

No Headlines